Share ownership PharmaBlock Sciences (Nanjing), Inc.

300725

CNE1000035K5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2026-06-11			5-day change	1st Jan Change
31.25 ^CNY	-2.25%		-9.42%	-18.96%

Jun. 04	PharmaBlock Sciences Commissions First Peptide Pilot-Scale GMP Plant At Zhejiang Site	CI
May. 13	Pharmablock Sciences, Inc. Approves Cash Dividend for the Year 2025, Payable on June 10, 2026	CI

Share class: PharmaBlock Sciences (Nanjing), Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	233,807,341	176,001,912 ( 75.28 %)	0	75.28 %

Major shareholders: PharmaBlock Sciences (Nanjing), Inc.

Name	Stocks	%	Valuation
Min Min Yang 5.468 %	10,350,830	5.468 %	54 M ¥
Quan Zhou 3.09 %	5,849,090	3.09 %	30 M ¥
Henan Hengtong Boyuan Venture Capital LP 2.076 %	3,929,592	2.076 %	20 M ¥
Yi Jun Shi 1.61 %	3,047,030	1.61 %	16 M ¥
China Southern Asset Management Co., Ltd. 1.134 %	2,146,711	1.134 %	11 M ¥
Penghua Fund Management Co., Ltd. 1.051 %	1,990,264	1.051 %	10 M ¥
Nanjing Novicos Venture Capital LP 1.05 %	1,986,600	1.05 %	10 M ¥
China Asset Management Co., Ltd. 0.7232 %	1,368,880	0.7232 %	7 M ¥
Hongde Fund Management Co., Ltd. 0.6759 %	1,279,444	0.6759 %	7 M ¥
Nai Bin Cheng 0.642 %	1,215,200	0.642 %	6 M ¥
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Stocks	%	Valuation
Min Min Yang 99.87 %	31,052,489	99.87 %	162 M ¥
Chen Chen 0.1317 %	40,950	0.1317 %	213 506 ¥

Breakdown by shareholder type

Individuals	28.64%
Institutional	5.73%
Others	3.13%
Unknown	62.5%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	28.64%
China	8.67%
Hong Kong	0.19%

Based on 1000 largest holdings

PharmaBlock Sciences Nanjing Inc is a China-based company principally engaged in the provision of innovative chemical products and services in the fields of pharmaceutical research and manufacturing. The Company is mainly engaged in providing innovative chemical products and related technical services for the research and development of small molecule drugs, covering the design, synthesis, and sales of drug molecular blocks. The Company also provides chemical research and development services for drug discovery, as well as process development and production services for intermediates, active pharmaceutical ingredients, and drug formulations for preclinical, clinical development, and commercialization projects. The Company provides products and services in the drug research phase, as well as products and services in the drug development and commercialization phase.

Employees

2,593

Sector

Pharmaceuticals

More about the company